455 On Other Exchanges
Symbol
Exchange
455 is not on other exchanges.

tianda pharmaceuticals ltd (455) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TIANDA PHARMACEUTICALS LTD (455)

Related News

No related news articles were found.

tianda pharmaceuticals ltd (455) Related Businessweek News

No Related Businessweek News Found

tianda pharmaceuticals ltd (455) Details

Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products. It offers cardio-cerebrovascular, pediatric, cold and respiratory system, anti-infective, and detoxification drugs, as well as complementary health care products comprising bone health, heart health, immune booster, nutritional oil, vitamin and mineral, women’s nutrition, wellbeing, and personal care products. The company also provides medicines for drug addicts and other pharmaceutical products, as well as healthcare products under the Herb Valley series. It primarily operates in the People’s Republic of China, Hong Kong, and Australia. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. Tianda Pharmaceuticals Limited is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.

424 Employees
Last Reported Date: 12/22/16

tianda pharmaceuticals ltd (455) Top Compensated Officers

Managing Director and Executive Director
Total Annual Compensation: $1.5M
Compensation as of Fiscal Year 2016.
tianda pharmaceuticals ltd
Tianda Pharmaceuticals Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended 30 September 2016

Tianda Pharmaceuticals Limited reported unaudited consolidated earnings results for the six months ended 30 September 2016. For the period, revenue was HKD 93,853,493 against HKD 102,473,766 a year ago. Profit before tax was HKD 20,715,499 against HKD 9,788,277 a year ago. Profit for the period attributable to owners of the company was HKD 11,525,520 against HKD 2,793,354 a year ago. Basic earnings per share were 0.54 cents against 0.14 cents a year ago.

Tianda Pharmaceuticals Limited to Report First Half, 2017 Results on Nov 25, 2016

Tianda Pharmaceuticals Limited announced that they will report first half, 2017 results on Nov 25, 2016

Tianda Pharmaceuticals Limited, Board Meeting, Nov 25, 2016

Tianda Pharmaceuticals Limited, Board Meeting, Nov 25, 2016. Agenda: To approve unaudited financial statements of the company and its subsidiaries and announcement of interim results for the six months ended September 30, 2016.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

455 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 455.
View Industry Companies
 

Industry Analysis

455

Industry Average

Valuation 455 Industry Range
Price/Earnings 59.7x
Price/Sales 5.0x
Price/Book 1.1x
Price/Cash Flow 59.7x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TIANDA PHARMACEUTICALS LTD, please visit www.tiandapharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.